Status:
UNKNOWN
The Validity of Novel Non-invasive Inflammatory Markers for Monitoring of Patients With Ulcerative Colitis
Lead Sponsor:
Assiut University
Conditions:
IBD, Non Invasive Markers,IL6,Lactoferrin,Ferritin
Eligibility:
All Genders
18-80 years
Brief Summary
Ulcerative Colitis (UC) is a disease known for repeated relapses and remissions. So, meticulous follow-up is required to individualize treatment plans according to the status of each patient. The curr...
Detailed Description
Introduction: Ulcerative Colitis (UC) is a disease known for repeated relapses and remissions. So, meticulous follow-up is required to individualize treatment plans according to the status of each pat...
Eligibility Criteria
Inclusion
- \- Patients who are newly diagnosed to be ulcerative colitis. Patients \>18 years old.
Exclusion
- Patients who are \>18 years old. Pregnant patients . Patients with colonic malignancies.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04670250
Start Date
June 1 2021
End Date
December 1 2022
Last Update
December 17 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.